Skip to main content
. Author manuscript; available in PMC: 2019 May 3.
Published in final edited form as: Psychiatr Serv. 2009 Apr;60(4):520–527. doi: 10.1176/ps.2009.60.4.520

Figure 3.

Figure 3

Time to treatment discontinuation and switching or augmentation of initial drug therapy among newly treated patients before and during implementation of a prior-authorization policya aDiscontinuation was defined as ≥30 days without any study drug therapy after the initial medication regimen. The prepolicy observation period was July 2002 through February 2003; the policy observation period was July 2003 through February 2004.